Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer

被引:0
|
作者
Noel Pabalan
Ofelia Francisco-Pabalan
Lillian Sung
Hamdi Jarjanazi
Hilmi Ozcelik
机构
[1] Saint Louis University,College of Natural Sciences
[2] University Health Network,Analytical Genetics Technology Centre, Princess Margaret Hospital
[3] Hospital for Sick Children,Division of Hematology/Oncology
[4] Ontario Ministry of the Environment,Environmental Monitoring and Reporting Branch
[5] Mount Sinai Hospital,Fred A. Litwin Centre for Cancer Genetics, Samuel Lunenfeld Research Institute
来源
Breast Cancer Research and Treatment | 2010年 / 124卷
关键词
Breast cancer; ERCC2; XPD; Asp312Asn; Lys751Gln; Adducts;
D O I
暂无
中图分类号
学科分类号
摘要
The excision repair cross-complementing group 2 gene (ERCC2) plays a key role in DNA repair. Several polymorphisms in the ERCC2 gene have been described, including the commonly occurring Lys751Gln and Asp312Asn polymorphisms. Studies investigating the association of these polymorphisms with breast cancer risk produced controversial results. To evaluate these associations presented in diverse populations, we have conducted a meta-analysis based on 40 studies from 33 publications in PubMed which included analyses of Lys751Gln (14,545 cases, 15,352 controls) and Asp312Asn polymorphisms (16,254 cases, 14,006 controls). Overall findings of both polymorphisms have implicated null effects (OR = 1.01–1.03) when the analyses were limited to the statistically powerful (≥80%) studies. Although modestly increased statistically significant breast cancer risk was detected in the underpowered studies (≤80%), removal of outliers resulted in null associations. Ethnic stratification showed non-significant and relatively null associations for both polymorphisms with breast cancer risk for the overall Caucasians as well as North American and the European sub-populations. Although statistically increased and decreased risks were observed for the homogenous populations of African-Americans (Lys751Gln, OR 1.25, 95% CI 1.03–1.53, P = 0.03) and Asians (Asp312Asn, ORs: 0.53–0.55, P values: 0.02–0.03), respectively, this may be the result of small sample size. Analyses of the homogeneous adduct studies, with relatively large sample size, exhibited increased risk for Lys751Gln (OR 1.20, 95% CI (1.02–1.41), P = 0.03) and Asp312Asn (OR 1.17 95% CI 1.02–1.34, P = 0.03) under the dominant genetic model. In conclusion, our results suggest null associations of both polymorphisms in the overall and the Caucasian subgroups, although some effects can be suggested for relatively smaller minority studies. Increased risk effect was more visible when the adduct studies are considered, suggesting the role of these polymorphisms in the presence of exposure to DNA damaging agents.
引用
收藏
页码:531 / 541
页数:10
相关论文
共 50 条
  • [31] XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies
    Ding, Da-Peng
    Ma, Wen-Li
    He, Xiao-Feng
    Zhang, Ying
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (03) : 2533 - 2540
  • [32] Significant Association of XPD Asp312Asn Polymorphism with Breast Cancer in Taiwanese Patients
    Wang, Hwei-Chung
    Liu, Chiu-Shong
    Wang, Chung-Hsing
    Tsai, Ru-Yin
    Tsai, Chia-Wen
    Wang, Rou-Fen
    Chang, Chao-Hsiang
    Chen, Yueh-Sheng
    Chiu, Chang-Fang
    Bau, Da-Tian
    Huang, Chih-Yang
    CHINESE JOURNAL OF PHYSIOLOGY, 2010, 53 (02): : 130 - 135
  • [33] The ERCC2/XPD Lys751Gln polymorphism affects DNA repair of benzo[a]pyrene induced damage, tested in an in vitro model
    Xiao, Sha
    Cui, Su
    Lu, Xiaobo
    Guan, Yangyang
    Li, Dandan
    Liu, Qiufang
    Cai, Yuan
    Jin, Cuihong
    Yang, Jinghua
    Wu, Shengwen
    van der Straaten, Tahar
    TOXICOLOGY IN VITRO, 2016, 34 : 300 - 308
  • [34] The Impact of the ERCC2 Lys751Gln Polymorphism on the Risk of Acute Myeloid Leukemia in an Iraqi Patients
    Jasiem, Thamer Mouhi
    Al-Hussaini, Rand Muhammed Abdul -Hussain
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2023, 9 (01): : 24 - 27
  • [35] The association between XPD Asp312Asn polymorphism and lung cancer risk: a meta-analysis including 16,949 subjects
    Zhang, Jian
    Qiu, Li-Xin
    Leaw, Shiang-Jiin
    Hu, Xi-Chun
    Chang, Jian-Hua
    MEDICAL ONCOLOGY, 2011, 28 (03) : 655 - 660
  • [36] The association between XPD Asp312Asn polymorphism and lung cancer risk: a meta-analysis including 16,949 subjects
    Jian Zhang
    Li-Xin Qiu
    Shiang-Jiin Leaw
    Xi-Chun Hu
    Jian-Hua Chang
    Medical Oncology, 2011, 28 : 655 - 660
  • [37] Associations between XPD Asp312Asn Polymorphism and Risk of Head and Neck Cancer: A Meta-Analysis Based on 7,122 Subjects
    Hu, Yuan Yuan
    Yuan, Hua
    Jiang, Guang Bing
    Chen, Ning
    Wen, Li
    Leng, Wei Dong
    Zeng, Xian Tao
    Niu, Yu Ming
    PLOS ONE, 2012, 7 (04):
  • [38] Association of genetic polymorphisms in DNA repair genes ERCC2 Asp312Asn (rs1799793), ERCC2 Lys 751 Gln (rs13181), XRCC1 Arg399 Gln (rs25487) and XRCC3 Thr 241Met (rs861539) with the susceptibility of lung cancer in Saudi population
    Alsagaby, Suliman
    Ahmed, Ahmed A.
    Rasheed, Zafar
    Althwab, Sami A.
    Aljohani, Abdullah S. M.
    Alhumaydhi, Fahad A.
    Alhomaidan, Homaidan T.
    Alkhamiss, Abdullah S.
    Alkhowailed, Mohammad
    Alaqeel, Aqeel
    Alblihed, Mohamd A.
    Alrehaili, Jihad
    Fernandez, Nelson
    Al Abdulmonem, Waleed
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2022, 41 (5-6) : 530 - 554
  • [39] Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) Polymorphisms in Familial and Sporadic Breast Cancer Predisposition and Survival: An Indian Report
    Syamala, Volga S.
    Syamala, Vani
    Sreedharan, Hariharan
    Raveendran, Praveenkumar B.
    Kuttan, Ratheesan
    Ankathil, Ravindran
    PATHOLOGY & ONCOLOGY RESEARCH, 2009, 15 (03) : 389 - 397
  • [40] ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma
    Schrama, David
    Scherer, Dominique
    Schneider, Michael
    Zapatka, Marc
    Broecker, Eva-Bettina
    Schadendorf, Dirk
    Ugurel, Selma
    Kumar, Rajiv
    Becker, Juergen C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (06) : 1280 - 1290